Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
[4-(5-Cyclopropyl-3-methylpyridin-2-yl)piperazin-1-yl](4-iodophenyl)methanone → HCID 71252693, 화합물
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | [4-(5-Cyclopropyl-3-methylpyridin-2-yl)piperazin-1-yl](4-iodophenyl)methanone | HCID 58484841 | — |
| 반응물 | (S)-4-methylisothiazolidine 1,1-dioxide | HCID 86676774 | — |
| 생성물 | HCID 71252693 | HCID 71252693 | 40% |
반응 단계
Using (S)-4-methylisothiazolidine 1,1-dioxide (240 mg) described in Preparation Example 4 and [4-(5-cyclopropyl-3-methylpyridin-2-yl)piperazin-1-yl](4-iodophenyl)methanone (650 mg) described in Preparation Example 117 and by the reaction and treatment in the same manner as in Example 1, the title compound (264 mg) was obtained.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08816079B2 |
| 출처 데이터셋 | uspto-grants-2014_08 |
| ORD ID | ord-fa1a16feabc34bc49b8b99a3d719dcce |
| 출처 메모 | uspto-grants-2014_08 |